Monoclonal antibody BCM 43-daunorubicin conjugateAlternative Names: BCM 43-DNR conjugate
Latest Information Update: 12 Feb 2007
At a glance
- Originator BCM Oncologia
- Class Monoclonal antibodies
- Mechanism of Action DNA intercalators; DNA topoisomerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Ovarian cancer
Most Recent Events
- 19 Jan 2000 Preclinical development for Ovarian cancer in Canada (unspecified route)